Free tool
FAERS Monitor: Glycine 1.5% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018315 or its brand name (Glycine 1.5% In Plastic Container, Glycine). Reports on generic versions are filed under their own applications.
Reports
329
Serious
262
80% of reports
Hospitalization
142
Death reported
28
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective37
- nausea29
- pneumonia27
- off label use26
- fatigue25
- condition aggravated24
- rash23
- insomnia22
- status epilepticus22
- stevens-johnson syndrome22
- depressed level of consciousness21
- sopor21
- diarrhoea18
- headache18
- pain16
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 10 |
| 2013 | 10 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 18 |
| 2017 | 35 |
| 2018 | 38 |
| 2019 | 11 |
| 2020 | 24 |
| 2021 | 20 |
| 2022 | 32 |
| 2023 | 25 |
| 2024 | 38 |
| 2025 | 27 |
| 2026 | 20 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,830 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| status epilepticusSignal | 22 | 124.8 | 83.3 | 2,576 |
| soporSignal | 21 | 101.5 | 67.1 | 1,988 |
| stevens-johnson syndromeSignal | 22 | 63.3 | 42.3 | 1,287 |
| depressed level of consciousnessSignal | 21 | 34.0 | 22.4 | 640 |
| pneumoniaSignal | 27 | 5.3 | 3.7 | 92 |
| insomniaSignal | 22 | 5.3 | 3.5 | 73 |
| condition aggravatedSignal | 24 | 5.0 | 3.4 | 75 |
| rashSignal | 23 | 3.4 | 2.3 | 37 |
| nauseaSignal | 29 | 2.3 | 1.7 | 22 |
| fatigueSignal | 25 | 2.1 | 1.4 | 13 |
| off label use | 26 | 1.9 | 1.3 | 11 |
| headache | 18 | 1.8 | 1.2 | 6 |
| drug ineffective | 37 | 1.8 | 1.3 | 13 |
| diarrhoea | 18 | 1.8 | 1.1 | 6 |
| pain | 16 | 1.7 | 1.0 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.